
Nerve Repair & Regeneration Market by Product (Biomaterials, Neurostimulation & Neuromodulation Devices), Application (Direct Nerve Repair/Neurorrhaphy, Nerve Grafting, Neurostimulation & Neuromodulation Surgeries), End-User - Global Forecast 2024-2030
Description
Nerve Repair & Regeneration Market by Product (Biomaterials, Neurostimulation & Neuromodulation Devices), Application (Direct Nerve Repair/Neurorrhaphy, Nerve Grafting, Neurostimulation & Neuromodulation Surgeries), End-User - Global Forecast 2024-2030
The Nerve Repair & Regeneration Market size was estimated at USD 10.10 billion in 2023 and expected to reach USD 11.43 billion in 2024, at a CAGR 13.27% to reach USD 24.18 billion by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Nerve Repair & Regeneration Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Nerve Repair & Regeneration Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Nerve Repair & Regeneration Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Acelity L.P. Inc., Alphatec Holdings, Inc., Axogen Corporation, B. Braun SE, Baxter International Inc., Boston Scientific Corporation, Checkpoint Surgical, Inc., Cigna Health and Life Insurance Company, Convatec Group plc, Integra Life Sciences Corporation, KLS Martin Group, Medtronic plc, Neuraptive Therapeutics, Inc., NuVasive, Inc., Orthofix International NV, Siemens Healthcare GmbH, Smith & Nephew plc, Stryker Corporation, and Zimmer Biomet Holdings, Inc..
Market Segmentation & Coverage
This research report categorizes the Nerve Repair & Regeneration Market to forecast the revenues and analyze trends in each of the following sub-markets:
Product
Biomaterials
Nerve Conduits
Nerve Connectors
Nerve Protectors
Nerve Wraps
Neurostimulation & Neuromodulation Devices
External Neurostimulation Devices
Internal Neurostimulation Devices
Application
Direct Nerve Repair/Neurorrhaphy
Epineural Repair
Group Fascicular Repair
Perineural Repair
Nerve Grafting
Allografts
Autografts
Xenografts
Neurostimulation & Neuromodulation Surgeries
Stem Cell Therapy
End-User
Ambulatory Surgery Centers
Hospitals & Clinics
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Nerve Repair & Regeneration Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Nerve Repair & Regeneration Market?
3. What are the technology trends and regulatory frameworks in the Nerve Repair & Regeneration Market?
4. What is the market share of the leading vendors in the Nerve Repair & Regeneration Market?
5. Which modes and strategic moves are suitable for entering the Nerve Repair & Regeneration Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
194 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Nerve Repair & Regeneration Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Enlarging cases of neurological disorders across the globe
- 5.1.1.2. Increasing number of peripheral nerve injuries among geriatric population
- 5.1.1.3. Surging trend of sports and recreational activities
- 5.1.2. Restraints
- 5.1.2.1. Limited number of neuro surgeons and neuro physicians worldwide
- 5.1.3. Opportunities
- 5.1.3.1. Emerging innovation in peripheral nerve regeneration techniques
- 5.1.3.2. Ongoing advancements in tissue engineering and regenerative medicine
- 5.1.4. Challenges
- 5.1.4.1. Concern regarding functional recovery issues after nerve repair surgery
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Nerve Repair & Regeneration Market, by Product
- 6.1. Introduction
- 6.2. Biomaterials
- 6.3.1. Nerve Conduits
- 6.3.2. Nerve Connectors
- 6.3.3. Nerve Protectors
- 6.3.4. Nerve Wraps
- 6.3. Neurostimulation & Neuromodulation Devices
- 6.4.1. External Neurostimulation Devices
- 6.4.2. Internal Neurostimulation Devices
- 7. Nerve Repair & Regeneration Market, by Application
- 7.1. Introduction
- 7.2. Direct Nerve Repair/Neurorrhaphy
- 7.3.1. Epineural Repair
- 7.3.2. Group Fascicular Repair
- 7.3.3. Perineural Repair
- 7.3. Nerve Grafting
- 7.4.1. Allografts
- 7.4.2. Autografts
- 7.4.3. Xenografts
- 7.4. Neurostimulation & Neuromodulation Surgeries
- 7.5. Stem Cell Therapy
- 8. Nerve Repair & Regeneration Market, by End-User
- 8.1. Introduction
- 8.2. Ambulatory Surgery Centers
- 8.3. Hospitals & Clinics
- 9. Americas Nerve Repair & Regeneration Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
- 10. Asia-Pacific Nerve Repair & Regeneration Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
- 11. Europe, Middle East & Africa Nerve Repair & Regeneration Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
- 12. Competitive Landscape
- 12.1. FPNV Positioning Matrix
- 12.2. Market Share Analysis, By Key Player
- 12.3. Competitive Scenario Analysis, By Key Player
- 12.3.1. Merger & Acquisition
- 12.3.1.1. Axonics Acquired Technology to Facilitate Easier and Faster Placement of Implantable Leads for Sacral Neuromodulation
- 12.3.2. Agreement, Collaboration, & Partnership
- 12.3.2.1. Minnesota Partnership for Biotechnology and Medical Genomics awarded three collaborative research grants
- 12.3.2.2. Toyobo launched major marketing initiative for Nerbridge(TM) in the U.S., setting sights on the global nerve conduit market
- 12.3.3. New Product Launch & Enhancement
- 12.3.3.1. LivaNova introduced SenTiva DUO implantable pulse generator for epilepsy
- 12.3.3.2. Checkpoint Surgical launched CHECKPOINT GEMINI Bipolar Nerve Stimulator for precise stimulation
- 12.3.3.3. Checkpoint Surgical introduced new nerve cutting kit
- 12.3.3.4. Axogen, Inc. Announced Positive Topline Results from Phase 3 RECON(SM) Study for Avance Nerve Graft
- 12.3.4. Investment & Funding
- 12.3.4.1. BioCircuit Technologies, Inc. Closes a USD 9 million Series Seed Round
- 12.3.4.2. MicroTransponder received macro funding round with USD 73M for stroke rehab neurostimulator
- 12.3.5. Award, Recognition, & Expansion
- 12.3.5.1. FDA cleared Neuspera Medical peripheral nerve stim
- 12.3.5.2. FDA Approves Abbott's Spinal Cord Stimulation For People Living With Painful Diabetic Peripheral Neuropathy
- 12.3.5.3. BioCircuit Technologies Announced FDA 510(k) Clearance of Nerve Tape Device
- 13. Competitive Portfolio
- 13.1. Key Company Profiles
- 13.1.1. Abbott Laboratories
- 13.1.2. Acelity L.P. Inc.
- 13.1.3. Alphatec Holdings, Inc.
- 13.1.4. Axogen Corporation
- 13.1.5. B. Braun SE
- 13.1.6. Baxter International Inc.
- 13.1.7. Boston Scientific Corporation
- 13.1.8. Checkpoint Surgical, Inc.
- 13.1.9. Cigna Health and Life Insurance Company
- 13.1.10. Convatec Group plc
- 13.1.11. Integra Life Sciences Corporation
- 13.1.12. KLS Martin Group
- 13.1.13. Medtronic plc
- 13.1.14. Neuraptive Therapeutics, Inc.
- 13.1.15. NuVasive, Inc.
- 13.1.16. Orthofix International NV
- 13.1.17. Siemens Healthcare GmbH
- 13.1.18. Smith & Nephew plc
- 13.1.19. Stryker Corporation
- 13.1.20. Zimmer Biomet Holdings, Inc.
- 13.2. Key Product Portfolio
- 14. Appendix
- 14.1. Discussion Guide
- 14.2. License & Pricing
- FIGURE 1. NERVE REPAIR & REGENERATION MARKET RESEARCH PROCESS
- FIGURE 2. NERVE REPAIR & REGENERATION MARKET SIZE, 2023 VS 2030
- FIGURE 3. NERVE REPAIR & REGENERATION MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. NERVE REPAIR & REGENERATION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. NERVE REPAIR & REGENERATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. NERVE REPAIR & REGENERATION MARKET DYNAMICS
- FIGURE 7. NERVE REPAIR & REGENERATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
- FIGURE 8. NERVE REPAIR & REGENERATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. NERVE REPAIR & REGENERATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
- FIGURE 10. NERVE REPAIR & REGENERATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. NERVE REPAIR & REGENERATION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
- FIGURE 12. NERVE REPAIR & REGENERATION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. AMERICAS NERVE REPAIR & REGENERATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 14. AMERICAS NERVE REPAIR & REGENERATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. UNITED STATES NERVE REPAIR & REGENERATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 16. UNITED STATES NERVE REPAIR & REGENERATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. ASIA-PACIFIC NERVE REPAIR & REGENERATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 18. ASIA-PACIFIC NERVE REPAIR & REGENERATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NERVE REPAIR & REGENERATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NERVE REPAIR & REGENERATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. NERVE REPAIR & REGENERATION MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 22. NERVE REPAIR & REGENERATION MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.